Sectoral Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-451,631
Closed -$6.1M 196
2020
Q1
$6.1M Sell
451,631
-296,966
-40% -$5.63M 1.17% 40
2019
Q4
$18.1M Sell
748,597
-342,937
-31% -$7.1M 2.7% 7
2019
Q3
$21M Buy
1,091,534
+135,498
+14% +$3.1M 3.62% 6
2019
Q2
$28.3M Buy
956,036
+116,082
+14% +$4.47M 3.38% 7
2019
Q1
$39.9M Sell
839,954
-294,000
-26% -$12.9M 4.8% 2
2018
Q4
$40.9M Buy
1,133,954
+356,484
+46% +$16.7M 5.56% 2
2018
Q3
$47.9M Buy
777,470
+161,600
+26% +$10.4M 5.08% 2
2018
Q2
$41.6M Buy
615,870
+77,252
+14% +$4.32M 4.65% 2
2018
Q1
$29.2M Buy
538,618
+169,821
+46% +$9.5M 3.2% 6
2017
Q4
$22M Sell
368,797
-4,599
-1% -$279K 2.75% 14
2017
Q3
$18.1M Sell
373,396
-29,278
-7% -$1.6M 2.34% 22
2017
Q2
$21.2M Buy
402,674
+13,251
+3% +$617K 2.31% 18
2017
Q1
$17.7M Buy
389,423
+154,125
+66% +$6.87M 2.06% 22
2016
Q4
$8.91M Sell
235,298
-13,902
-6% -$526K 0.99% 28
2016
Q3
$9.4M Buy
249,200
+160,800
+182% +$3.55M 0.92% 34
2016
Q2
$1.56M Buy
+88,400
New +$1.43M 0.16% 55

Other funds holding AERI

Sectoral Asset Management's AERI Position: Q2 2020 in Review

Sectoral Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 451,631 shares — an estimated $6.1M sold.

Sectoral Asset Management first reported a position in AERI in Q2 2016 and held it in 16 quarters. The position peaked at $47.9M in Q3 2018. 155 funds tracked by Wall St. Rank hold AERI as of Q2 2020.

  • Sectoral Asset Management reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Sectoral Asset Management sold 451,631 Aerie Pharmaceuticals shares in Q2 2020, an estimated $6.1M.
  • Sectoral Asset Management first reported a position in Aerie Pharmaceuticals in Q2 2016 and held it in 16 quarters.
  • Sectoral Asset Management's Aerie Pharmaceuticals position peaked at $47.9M in Q3 2018.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.

Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.